These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7285029)

  • 21. [Effect of vasodilator agents in chronic heart failure].
    Bussmann WD
    Med Klin; 1981 Apr; 76(9):249-53. PubMed ID: 6456408
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of red rest and prazosin in congestive heart failure.
    Thaulow E; Ihlen H; Kjekshus J; Forfang K; Storstein O
    Acta Med Scand; 1982; 212(3):131-6. PubMed ID: 7148503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Wagner GC; Robinson PH
    Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858
    [No Abstract]   [Full Text] [Related]  

  • 27. [Peripheral vasodilator agents in cardiology].
    Khomenko VL; Pomerantsev VP; Vasiuk IuA
    Sov Med; 1980; (12):70-5. PubMed ID: 6784251
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of vasodilators in congestive heart failure.
    Conti CR; Mehta J; Pepine CJ; Nichols WW
    Adv Cardiol; 1980; 27():313-21. PubMed ID: 6778088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chronic vasodilator treatment in heart failure. II. Prazosin therapy].
    Costică II; Dumitriu M; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):397-403. PubMed ID: 6151226
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines for vasodilator therapy of congestive heart failure in infants and children.
    Artman M; Graham TP
    Am Heart J; 1987 Apr; 113(4):994-1005. PubMed ID: 3031972
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of cardiac insufficiency with systemic vasodilator agents].
    García Puig J; Gil Aguado A; Arnalich F; Gaspar G; Anciones B; Vázquez JJ
    Med Clin (Barc); 1980 Nov; 75(9):398-403. PubMed ID: 7464335
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of vasodilator agents in circulatory insufficienty].
    Halawa B
    Wiad Lek; 1979 Nov; 32(22):1617-20. PubMed ID: 120075
    [No Abstract]   [Full Text] [Related]  

  • 34. [Peripheral vasodilators in the treatment of heart failure].
    Serbin VI; Gasanova AS
    Pediatriia; 1982 Jan; (1):67-70. PubMed ID: 7038611
    [No Abstract]   [Full Text] [Related]  

  • 35. Symposium on Congestive Heart Failure. Introduction.
    Conti CR
    Am J Med; 1981 Jul; 71(1):131-4. PubMed ID: 7246570
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemodynamic effects of prazosin in chronic congestive heart failure].
    Bassand JP; Becque O; Berthout P; Vial Y; Magnin D; Bernard Y; Maurat JP
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):747-56. PubMed ID: 6779769
    [No Abstract]   [Full Text] [Related]  

  • 37. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin.
    Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Echocardiographic, hemodynamic and clinical effects of prazosin in subjects with severe cardiopathy caused by Chagas disease].
    Pileggi F; Bellotti G; Galiano N; de Moraes V; Ramires JA; de Mello CP; Décourt LV
    Cardiology; 1980; 66 Suppl 2():177-85. PubMed ID: 7285028
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
    Packer M; Meller J; Gorlin R; Herman MV
    Circulation; 1979 Mar; 59(3):531-9. PubMed ID: 761333
    [No Abstract]   [Full Text] [Related]  

  • 40. [Prazosin in heart insufficiency. Short-term hospital clinical trial].
    Sánchez Domińguez J; González Villa J; Urbina Fuentes FJ; Menéndez Lozano A
    Rev Clin Esp; 1981 Mar; 160(6):371-6. PubMed ID: 7255801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.